Nice to meet you lucky. I don't think IPCI has ever wanted to target the immediate release market. I somehow recall reading early storyline stuff about how Dr. Odidi only wanted to develop hard to manufacture generics and opioid based NDA's.
But when IPCI's generics pipeline turned into the total and complete disaster it has over the past 3.5 years I really have no clue if even Dr. Odidi has a solid growth plan anymore.
Everything we've seen unfold over the past 2 years alone sure tends to suggest that as a scientist he's clueless as it comes as to how to adjust IPCI's growth model when the generics have turned into the disaster they turned into glty.
News 
Market Data 
Discover 
